Taj Pharma India Limited – Sarigam, GIDC, Gujarat
Taj Pharma India Limited: Leading Pharmaceutical Excellence in Sarigam, Gujarat

Taj Pharma Group has established itself as a pioneering force in the pharmaceutical industry, recognized for its unwavering commitment to innovation, quality, and global healthcare accessibility. Founded in 2004, Taj Pharma has rapidly grown to become a trusted name across over 27 countries. With state-of-the-art facilities, research-driven advancements, and an expansive product portfolio, the company continues to shape the future of healthcare on a global scale.


State-of-the-Art Manufacturing Facilities

Non-Beta Lactam Manufacturing Excellence

At M/s Taj Pharma India Ltd., we operate a world-class manufacturing facility that meets the highest standards of quality and compliance. This facility is EU-GMP, WHO-GMP Approved, and ISO 9001-2015 Certified, making it a hallmark of reliability and excellence. Designed to adhere to stringent regulatory guidelines such as EU-GMP, MHRA, and PIC/S, the facility is equipped for large-scale production of:

  • Tablets
  • Capsules
  • Dry Syrups
  • Effervescent Tablets
  • Oncology-Specific Oral Solid Dosage Forms (OSDs)

Our technologically advanced operations ensure that we meet the growing global demand for affordable and innovative medicines.

Cephalosporin Manufacturing

Discover Block 3 Viramgam by Taj Pharmaceuticals - a state-of-the-art facility near Ahmedabad, ensuring high-quality drug production with advanced technology and stringent standards.
Block 3 Viramgam: Taj Pharmaceuticals’ Pinnacle of Excellence

Our dedicated Cephalosporin manufacturing facility at M/s Taj Pharma Laboratory Pvt. Ltd. sets a benchmark in quality and specialization. Designed exclusively for Beta Lactam products, this cutting-edge facility adheres to PICS, WHO, and EU guidelines and specializes in the production of:

  • Tablets
  • Capsules
  • Dry Syrups
  • Directly Compressible (DC) Granules

The incorporation of cGMP (Current Good Manufacturing Practices) ensures consistent product quality, allowing us to cater to both domestic and international markets with unmatched efficiency.

API and Intermediate Production

At M/s Taj Pharma Industries LLP, we have developed a state-of-the-art Greenfield Facility that includes four dedicated blocks for producing:

  1. Active Pharmaceutical Ingredients (APIs)
  2. Intermediates
  3. Fine Chemicals

This facility is designed in strict compliance with the latest Environmental, Health, and Safety (EHS) guidelines, showcasing our commitment to sustainability and regulatory excellence. By prioritizing quality and innovation, we deliver API solutions that serve diverse industries globally.


Specialized Product Categories

Oncology and Nephrology Products

Our specialized facilities for Oncology and Nephrology products focus on producing high-quality Tablets and Capsules. These are designed to meet the critical needs of patients requiring advanced therapeutic solutions, ensuring efficacy and affordability.

General and Beta Lactam Products

We offer an extensive range of Non-Beta Lactam and Beta Lactam products, including:

  • Tablets
  • Capsules
  • Dry Syrups
  • Pellets
  • DC Granules
  • Sachets

This specialization ensures precision and efficiency, meeting the diverse healthcare needs of patients across the globe.


Cutting-Edge Research and Development

Innovation at the Core

Our DSIR-approved R&D center is a cornerstone of our success. It is dedicated to:

  • Developing new formulations and advanced drug delivery systems.
  • Conducting rigorous testing to ensure product safety and efficacy.
  • Innovating cost-effective and sustainable manufacturing processes.

This relentless focus on research enables us to stay ahead in the competitive pharmaceutical landscape, consistently delivering breakthroughs that transform lives.


Global Reach: Serving Over 27 Countries

With an extensive distribution network, Taj Pharma Group has established its presence in key regions, including:

  • Asia: India, Vietnam, Philippines, Sri Lanka, Afghanistan, and Nepal.
  • Africa: Nigeria, Ghana, Kenya, Ethiopia, and Uganda.
  • Middle East: Iran, Iraq, Yemen, and Syria.
  • Latin America: Bolivia, Dominican Republic, Costa Rica, and Venezuela.

Our global footprint ensures that high-quality, affordable medicines are accessible to millions, transcending geographical and socio-economic barriers.


Global Accreditations: A Mark of Excellence

Taj Pharma Group’s unwavering commitment to quality and compliance is reflected in its numerous international accreditations, including:

Taj Pharma
  • DPML, Cote D’Ivoire
  • DIGEMID, Peru
  • FDA, Philippines
  • TFDA, Tanzania
  • NAFDAC, Nigeria
  • FDA-MOH, Vietnam
  • NMRA, Sri Lanka

These certifications affirm our adherence to global regulatory standards, ensuring the safety and efficacy of our products.


Why Choose Taj Pharma Group?

1. Research-Driven Innovation

We invest heavily in R&D to pioneer advancements in pharmaceutical sciences, ensuring that we stay at the forefront of healthcare innovation.

2. Uncompromising Quality

Every product is manufactured under strict quality controls, meeting the most stringent global standards.

3. Global Accessibility

Our expansive distribution network ensures that life-saving medicines reach those who need them most, regardless of location.

4. Diverse Product Portfolio

From Non-Beta Lactam and Beta Lactam formulations to specialized Oncology and Nephrology products, our offerings cater to a wide range of healthcare needs.

5. Sustainability Focus

We operate with a strong commitment to environmental and social responsibility, aligning our practices with international EHS guidelines.


Taj Pharma Group continues to redefine the standards of excellence in the pharmaceutical industry. With state-of-the-art facilities, a commitment to research-driven innovation, and a robust global presence, we are dedicated to delivering affordable, high-quality healthcare solutions that transform lives worldwide.